showed a trendp = .12
When later events were included, both the REMoDL-B and LLMPP data showed similar results (OS HR = 2.11, 95% CI = 1.115–3.993; p = .019 and HR = 2.17, 95% CI = 1.109–4.242; p = .02; supplemental Figure 3 A,B, respectively), while the HMRN cohort showed a trend for reduced survival in the high-risk group, (HR = 1.39, 95% CI = 0.917–2.106; p = .12; supplemental Figure 3 C); and we have reasoned that the performance of the discriminator may reflect the number of non-lymphoma–related deaths in this population-based cohort.